Our technologies-澳门葡京网赌游戏

Cutting-edge technologies fuelling drug discovery

At AstraZeneca, we are constantly building and investing in cutting-edge technologies to fast-forward the pace of our science, helping us expand and accelerate our drug discovery and push the boundaries of science to achieve the next wave of breakthroughs.

We know that in order to advance our scientific knowledge to deliver life-changing medicines to the right patients at the right time, harnessing the power of data and technology is the absolute cornerstone. This is at the heart of our R&D culture – one of four essential elements that uniquely combine to power everything we do.

Our most exciting technologies and imaging platforms are all working together with one aim – to support us in advancing our scientific knowledge to extend the possible and help us shape the future of healthcare. Together these technologies are enabling us to enhance our understanding of disease biology with the aim of allowing us to treat, prevent, modify and even cure complex diseases, to discover new ways of targeting the drivers of disease to create the next generation of therapeutics, to better predict clinical success so we can accelerate the future delivery of medicines to patients and to pioneer new ways of engaging with patients in the clinic and beyond with a view to improve their experience and outcomes.

Explore our technologies

We understand that however innovative our science, however effective our medicines and delivery, to achieve what we want to achieve, we cannot do it alone. We now have access to world-class technologies, both internally and through our numerous collaborations, some of which can be explored here:

Our pioneering acoustic tube technology enables greater speed, accuracy, efficiency, agility and sustainability in the handling and processing of millions of compounds for biological screening.

Advanced molecular imaging is enabling our scientists to probe and analyse tissue samples in unprecedented depth to unveil their full molecular complexity.

Cryo-electron microscopy (cryo-EM) is a revolutionary, Nobel Prize-winning technology that allows scientists to visualise in exquisite detail the molecular structures of highly complex proteins.

Functional genomics, enabled by CRISPR, has transformed the landscape of target identification. Suppressing or activating specific genes and testing the effects on the markers of disease has never offered so much potential.

The ‘omics’ are largely untapped repositories of unimaginably rich information on the drivers of disease whose secrets are starting to be revealed through integration of datasets facilitated by advances in next generation sequencing and mass spectrometry technology.

The futuristic AstraZeneca iLab is our prototype of a fully automated medicinal chemistry laboratory which is propelling the design-make-test-analyse cycle of drug discovery to new heights of efficiency.

The people behind the technology

Drug discovery is powered not only by technology but also by people. Find out more about some of our researchers working at the cutting-edge of drug discovery: